Patent Eligibility 101: The Myriad Meanings of Alice

If you are an attorney interested in attending this program, please click the link below to email your name, title, company, contact information, and bar numbers for jurisdictions in which you are requesting credit. Once we receive this information, we will confirm your registration. 

Live Location 

Philadelphia, PA

Following the US Supreme Court’s decisions in Association for Molecular Pathology v. Myriad Genetics, Inc. (2013) and Alice Corp v. CLS Bank International (2014), the patentability of many biotech, software, and business method inventions under 35 U.S.C. §101 is in doubt. The Myriad and Alice cases lay out the test for whether inventions are patentable, but they fail to flesh out how to apply the test. This program will look at how the Court of Appeals for the Federal Circuit and other Article I and III courts have applied the Myriad and Alice test, to gain an understanding of what types of inventions are patent eligible.

CLE credit is pending in CA, CT, NJ, NY, PA, and TX.